Enhancing uterine receptivity for embryo implantation through controlled collagenase intervention
Life Science Alliance · 2024
DOI: 10.26508/lsa.202402656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Eldar Zehorai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: Embryo Implantation, Collagenases, Uterus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
Ineffective endometrial matrix remodeling, a key factor in infertility, impedes embryo implantation in the uterine wall. Our study reveals the cellular and molecular impact of human collagenase-1 administration in mouse uteri, demonstrating enhanced embryo implantation rates. Collagenase-1 promotes remodeling of the endometrial ECM, degrading collagen fibers and proteoglycans. This process releases matrix-bound bioactive factors (e.g., VEGF, decorin), facilitating vascular permeability and angiogenesis. Collagenase-1 elevates embryo implantation regulators, including NK cell infiltration and the key cytokine LIF. Remarkably, uterine tissue maintains structural integrity despite reduced endometrial collagen fiber tension. In-utero collagenase-1 application rescues implantation in heat stress and embryo transfer models, known for low implantation rates. Importantly, ex vivo exposure of human uterine tissue to collagenase-1 induces collagen de-tensioning and VEGF release, mirroring remodeling observed in mice. Our research highlights the potential of collagenases to induce and orchestrate cellular and molecular processes enhancing uterine receptivity for effective embryo implantation. This innovative approach underscores ECM remodeling mechanisms critical for embryo implantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
- Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
- Gynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center; Petah-Tikva and The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
- Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel inna.solomonov@weizmann.ac.il.
- Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel irit.sagi@weizmann.ac.il.
ORCID-Profile: Elee Shimshoni, Guillaume Molodij, Karl E Kadler, Orit Kollet, Michal Neeman, Inna Solomonov, Irit Sagi
Förderung
- Israel Science Foundation
Zitieren
APA
Zehorai, E., Gross Lev, T., Shimshoni, E., Hadas, R., Adir, I., Golani, O., Molodij, G., Eitan, R., Kadler, K. E., Kollet, O., Neeman, M., Dekel, N., Solomonov, I., & Sagi, I. (2024). Enhancing uterine receptivity for embryo implantation through controlled collagenase intervention. Life Science Alliance. https://doi.org/10.26508/lsa.202402656
Vancouver
Zehorai E, Gross Lev T, Shimshoni E, Hadas R, Adir I, Golani O, et al. Enhancing uterine receptivity for embryo implantation through controlled collagenase intervention. Life Science Alliance. 2024. doi:10.26508/lsa.202402656
BibTeX
@article{Zehorai2024,
author = {Zehorai, Eldar and Gross Lev, Tamar and Shimshoni, Elee and Hadas, Ron and Adir, Idan and Golani, Ofra and Molodij, Guillaume and Eitan, Ram and Kadler, Karl E and Kollet, Orit and Neeman, Michal and Dekel, Nava and Solomonov, Inna and Sagi, Irit},
title = {Enhancing uterine receptivity for embryo implantation through controlled collagenase intervention},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202402656}
}
EUVIMED